Skip to main content
. Author manuscript; available in PMC: 2010 Mar 12.
Published in final edited form as: Free Radic Biol Med. 2008 Aug 3;45(9):1232–1242. doi: 10.1016/j.freeradbiomed.2008.07.022

Fig. 4.

Fig. 4

Bak and Bax knockout block Bz-423 induced death. (A) Superoxide was measured using DHE in WT MEF (circles, solid line), Bax−/− MEF (squares, long dashes), Bak−/− MEF (diamonds, short dashes), and DKO MEF (“X”, dotted line) after treatment with Bz-423 (1 h). (B) Cytosolic fractions prepared from WT, Bax−/−, Bak−/−, and DKO MEF following treatment (12 h) with Bz-423 (12 μM) or control were analyzed for cytochrome c. (C) ΔΨm was measured using DIOC6(3) in WT, Bax−/−, Bak−/−, and DKO MEF following Bz-423 (12 h). (D) Apoptosis was determined by hypodiploid DNA content in WT (circles, solid line), Bax−/− (squares, long dashes), Bak−/− (diamonds, short dashes), and DKO MEFs (“X”, dotted line) following Bz-423 treatment (48 h). P < 0.01 for WT vs Bak−/−, Bax−/−, or DKO MEFs at all [Bz-423] > 5 μM, P < 0.01 for Bak−/− vs DKO MEFs at all [Bz-423] > 5 μM, P < 0.01 for Bax−/− vs DKO MEFs at all [Bz-423] > 7.5 μM. (E) Cell viability was determined by PI exclusion in WT, Bax−/−, Bak−/−, and DKO MEF following Bz-423 treatment (48 h). P < 0.05 for WT vs Bak−/− or Bax−/− MEFs at all [Bz-423] > 5 μM, P < 0.02 for WT vs DKO MEFs at all [Bz-423] ≥ 2.5 μM, P < 0.02 for Bak−/− vs DKO at [Bz-423] between 2.5 μM and 12.5 μM, P < 0.01 for Bax−/− vs DKO at all [Bz-423] > 2.5 μM.

HHS Vulnerability Disclosure